ArticleACS ES&T water2026
Monitoring Frequencies for On-Site Water Reuse: A Risk-Based Framework Applied to Greywater Reuse.
Article in ACS ES&T water, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On-site water reuse can provide water for nonpotable applications, but ensuring long-term performance and managing treatment failures is challenging without dedicated monitoring personnel. This study proposes a risk-based framework to determine enteric pathogen log-removal targets (LRTs) as a function of operational monitoring frequency. The framework integrates (i) quantitative microbial risk assessment, (ii) modeled pathogen concentrations at three collection scales, and (iii) failure models for three treatment configurations. As an example, LRTs were calculated considering different monitoring frequencies for greywater reuse. Results show that smaller systems require less frequent monitoring due to lower pathogen occurrence compared to larger systems, e.g., >1 day at a 5-people scale vs <500 s for a 1000-people system to meet norovirus risk with a bimodal treatment barrier failing up to four times per year. Incorporating a residual disinfectant or multiple barriers extends the required monitoring intervals. While LRTs are comparable across collection scales, this study highlights a key advantage of small systemsreduced monitoring requirementscontrasting prior work that found no benefits of downsizing in terms of treatment train design. This framework can support technology developers in quantifying trade-offs between treatment and monitoring and aid regulators in establishing monitoring requirements for on-site water reuse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.